| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.01 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |